ArticleEye (London, England)2026
Incidence and risk factors for retinopathy of prematurity: A hospital-based study in Iran.
Article in Eye (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo determine the incidence and risk factors for retinopathy of prematurity (ROP) in Razi Hospital, the only reference centre in South Khorasan Province, Birjand, Iran from 2019 to 2022.
methodsIn this retrospective cross-sectional study, medical records of all premature infants were reviewed and data extracted on ROP findings and maternal and postnatal risk factors. Logistic regression was used to evaluate risk factors for ROP.
results180 infants with gestational age (GA) < 34 weeks or birth weight (BW) ≤2000 grams (g), or larger, more mature infants with other risk factors for ROP, were included in the study. 55 infants (30.5%) developed ROP of any severity; most had stage 1 (54%) and zone 2 (55%) ROP. The mean GA and BW of infants with ROP were 30.4 ± 2.5 weeks and 1324.2 ± 308.2 g, respectively. In logistic regression analysis, factors statistically associated with ROP were GA (Odds ratio (OR): 1.28 (95% CI: 1.14 to 1.44), p < 0.001), BW (OR: 1.00 (95% CI: 1.00 to 1.00), p < 0.001), oxygen therapy (OR: 0.56 (95% CI: 0.34 to 0.92), p = 0.022), and sepsis (OR: 0.12 (95% CI: 0.02 to 0.78), p = 0.026). None of the maternal risk factors were associated with ROP.
conclusionThe incidence of 30.5% for ROP in this study is similar to reports from other studies in the region. The most important risk factors were GA, BW, oxygen therapy, and sepsis.
Identifiers
42581165What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.